Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Biomed Res Int ; 2013: 434191, 2013.
Article in English | MEDLINE | ID: mdl-24191244

ABSTRACT

The authors report their experience about the use of P.R.L. PLATELET RICH LIPOTRANSFERT method (platelet rich plasma mixed fat grafting) in 223 patients affected by soft tissue defects (ulcers, Romberg syndrome, Hemifacial atrophy, loss of substance, and signs of aging). This paper introduces the reader to PRP therapy and reviews the current literature on this emerging treatment modality, showing at the current clinical use of PRP in plastic and reconstructive surgery, with description of innovative methods and future prospects. This technique provides a promising alternative to surgery by promoting safe and natural healing. Here recent studies concerning the use of PRP in the treatment of chronic ulcers and soft tissue defect are reviewed.


Subject(s)
Adipose Tissue , Platelet-Rich Plasma , Surgery, Plastic/methods , Ulcer/therapy , Blood Platelets/pathology , Humans , Ulcer/pathology , Wound Healing
2.
Med Sci Law ; 52(4): 234-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23155126

ABSTRACT

There are a large number of publications describing the use of platelet-rich plasma (PRP) in multiple fields of application. These illustrate a large number of therapeutic elements with different and specific actions within 'platelet gel' (this term is used in the current regulations to define this product). This term, however, lacks specificity and, depending on the method used in its production is variable both in its blood composition and in platelet concentration, and several publications consider better and easier methods of platelet gel production, which may or may not lead to greater standardization in the product. The authors illustrate the general aspects of PRP and other blood components for non-transfusion use, briefly touching on the history and different fields of application and the rational of for its use. Given the increased use of such preparations, the authors describe critically the regulations in force in Europe and propose a new regulatory framework aimed to simplify and facilitate the use of such material as a therapeutic agent within medicine.


Subject(s)
Legislation, Medical , Platelet-Rich Plasma , Blood Component Transfusion/legislation & jurisprudence , Gels , Humans , Italy , Platelet-Rich Plasma/cytology , Platelet-Rich Plasma/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL